This overview has been developed for program planners considering introduction and/or expansion of the use of oxytocin, and in particular oxytocin packaged in the Uniject™ device, to reduce the incidence of postpartum hemorrhage as a component of their maternal and child health programming. Administering oxytocin is just one component of active management of third stage labor.

Corporate author(s): PATH

Publication date: September 2008

Available materials



Introducing Oxytocin in the Uniject™ Device: An Overview for Decision-Makers

131 KB PDF

Also known as: Introducción de Oxitocina en el Dispositivo Uniject™: Una Visión General Para Tomadores de Decisiones

Hard copies are not available.

Some digital files may be saved at low resolutions to conserve file size. Versions with higher quality may be available; see the contact information below to enquire.

Related regions: Global

See also:

For more information…

Contact: PATH Publications
Mailing address: PATH, PO Box 900922, Seattle, WA 98109 USA